JOHNSON & JOHNSON (JNJ) revenue & profit
JOHNSON & JOHNSON (JNJ): revenue $94.2B, net income $26.8B in 2025; latest quarter +6.6% year over year. From SEC filings.
$94.2BRevenue 2025
TickerJNJ (NYSE)
IndustryHealthcare · Pharmaceutical Preparations
Revenue 2025$94.2B
Net income 2025$26.8B
Net margin28.5%
Annual revenue growth+6%
Latest quarter (2026 Q2) · Revenue$25.3B
vs. same quarter last year+6.6%
Latest quarter · Net income$5.5B
Annual revenue & net income
| Year | Revenue | Net income | |
|---|---|---|---|
| 2022 | $80B | $17.9B | |
| 2023 | $85.2B | $35.2B | |
| 2024 | $88.8B | $14.1B | |
| 2025 | $94.2B | $26.8B |
ℹ️ Not investment advice. Calendar-year figures as tagged by the SEC; a company’s fiscal year may end in a different month.